Bliss GVS Pharma Ltd approves unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026
- Board meeting held by video conference on October 29, 2026.
- Results were accompanied by auditors’ limited review reports.
- Financial figures were not included in the announcement text provided.